Zobrazeno 1 - 10
of 177
pro vyhledávání: '"L. Pechet"'
Publikováno v:
Scandinavian Journal of Immunology. 36:653-660
Summary The study of the immunobiology of FVIII inhibitors may lead to new therapies for this potentially severe complication of haemophilia A and to new principles for the use of therapeutic proteins. In order to characterize the idiotype-anti-idiot
Publikováno v:
Journal of thrombosis and thrombolysis. 11(3)
TTP and HUS are two disorders with many similarities. Though their first descriptions appeared at different time in history, there has been a trend among physicians to consider them as the same clinical entity. However, in recent years new research f
Publikováno v:
Thrombosis and haemostasis. 85(1)
It is generally believed that platelets do not have a functionally significant protein synthetic machinery. However, our analysis demonstrated that normal bone marrow megakaryocytes express high levels of translation initiation factors eIF-4E and eIF
Autor:
S L, Senno, L, Pechet
Publikováno v:
Journal of thrombosis and thrombolysis. 8(2)
Plasminogen activator inhibitor (PAI-1), a member of the serine protein family, is the most active in vivo inhibitor of fibrinolysis induced by plasminogen, tissue plasminogen activator (tPA), and urokinase type plasminogen activator (uPA). While the
Autor:
M J, Misialek, L, Pechet
Publikováno v:
Acta haematologica. 98(4)
There exists a great deal of overlap between many myelodysplastic syndromes and myeloproliferative disorders. This is most evident in the spectrum of disorders classified under the term chronic myeloid leukemia. These include chronic granulocytic leu
Publikováno v:
Acta haematologica. 95(2)
Leukemias of megakaryocytic lineage are rare and heterogeneous clinical entities. The nomenclature published in the literature is confusing and perhaps inappropriate to designate these primary myeloproliferative disorders. We describe a patient with
Publikováno v:
Archives of pathologylaboratory medicine. 119(6)
To develop guidelines for laboratory tests ordered before admission for elective surgery.A seven-step continuous quality improvement process.The Departments of Laboratory Medicine, Surgery, and Anesthesia of the University of Massachusetts Medical Ce
Publikováno v:
Archives of pathologylaboratory medicine. 119(5)
In an attempt to improve physicians' laboratory practice behavior, the Department of Hospital Laboratories at the University of Massachusetts Medical Center developed a rotation for first year housestaff. Medical interns were chosen for this pilot pr
Publikováno v:
Archives of pathologylaboratory medicine. 118(10)
In 1991, the University of Massachusetts Medical Center, in Worcester, developed a model for change by using a program of continuous quality improvement to enhance physicians' laboratory-ordering practices, particularly the test for bleeding times. W
Publikováno v:
New England Journal of Medicine. 270:6-13
AN elevated prothrombin time as determined by the Quick1 procedure may be due to many abnormalities, including deficiency of factors I (fibrinogen), II (prothrombin), V (acheal-globulin), VII (proc...